Conformational disorders such as Alzheimer’s, Parkinson’s, familial amyloidotic polyneuropathy and spongiform encephalopaties are a consequence of protein misfolding and aggregation predominantly in the form of amyloid fibrils. These pathologies represent a major health problem, which most probably will overwhelm the health systems of developed countries in the near future. Significant progress has been made recently to understanding the underlying mechanism of protein misfolding and aggregation. The current picture of protein aggregation is a phenomenon resulting from protein conformational fluctuations leading to misfolded intermediates prone to form non-native interactions with other intermediates, resulting in amylo...
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/63704Protein misfolding and aggregat...
Protein aggregation trends in neurodegenerative diseases are largely unmapped due to the complex nat...
Protein aggregates are hallmarks of neurodegenerative diseases. The protein quality control (PQC) sy...
Fibrillar protein aggregation is a hallmark of a variety of human diseases. Examples include the dep...
Fibrillar protein aggregation is a hallmark of a variety of human diseases. Examples include the dep...
Fibrillar protein aggregation is a hallmark of a variety of human diseases. Examples include the dep...
The inability of a protein to adopt its native and soluble conformation (protein misfolding) is the ...
The amyloidoses constitute a large group of diseases caused by an alteration in the conformation and...
Protein misfolding and aggregation can be induced by a wide variety of factors, such as dominant dis...
Protein aggregation occurs in vivo as a result of improper folding or misfolding. Diverse diseases a...
Protein aggregation occurs in vivo as a result of improper folding or misfolding. Diverse diseases a...
AbstractDiverse human disorders, including several neurodegenerative diseases and systemic amyloidos...
Fibrillar protein aggregation is a hallmark of a variety of human diseases. Examples include the dep...
Misfolding and aggregation of proteins in tissues is linked to the onset of a diverse set of human n...
The amyloidoses constitute a large group of diseases caused by an alteration in the conformation and...
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/63704Protein misfolding and aggregat...
Protein aggregation trends in neurodegenerative diseases are largely unmapped due to the complex nat...
Protein aggregates are hallmarks of neurodegenerative diseases. The protein quality control (PQC) sy...
Fibrillar protein aggregation is a hallmark of a variety of human diseases. Examples include the dep...
Fibrillar protein aggregation is a hallmark of a variety of human diseases. Examples include the dep...
Fibrillar protein aggregation is a hallmark of a variety of human diseases. Examples include the dep...
The inability of a protein to adopt its native and soluble conformation (protein misfolding) is the ...
The amyloidoses constitute a large group of diseases caused by an alteration in the conformation and...
Protein misfolding and aggregation can be induced by a wide variety of factors, such as dominant dis...
Protein aggregation occurs in vivo as a result of improper folding or misfolding. Diverse diseases a...
Protein aggregation occurs in vivo as a result of improper folding or misfolding. Diverse diseases a...
AbstractDiverse human disorders, including several neurodegenerative diseases and systemic amyloidos...
Fibrillar protein aggregation is a hallmark of a variety of human diseases. Examples include the dep...
Misfolding and aggregation of proteins in tissues is linked to the onset of a diverse set of human n...
The amyloidoses constitute a large group of diseases caused by an alteration in the conformation and...
Podeu consultar el llibre complet a: http://hdl.handle.net/2445/63704Protein misfolding and aggregat...
Protein aggregation trends in neurodegenerative diseases are largely unmapped due to the complex nat...
Protein aggregates are hallmarks of neurodegenerative diseases. The protein quality control (PQC) sy...